These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35219858)

  • 21. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
    Wu F; Qiu F; Wai-Keong SA; Diao Y
    Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimuli-responsive Carriers for Controlled Intracellular Drug Release.
    Sheng Y; Hu J; Shi J; Lee LJ
    Curr Med Chem; 2019; 26(13):2377-2388. PubMed ID: 28875840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer.
    Oshiro-Júnior JA; Rodero C; Hanck-Silva G; Sato MR; Alves RC; Eloy JO; Chorilli M
    Curr Med Chem; 2020; 27(15):2494-2513. PubMed ID: 30306849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimuli-Responsive Boron-Based Materials in Drug Delivery.
    Das BC; Chokkalingam P; Masilamani P; Shukla S; Das S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smart synthetic polymer nanocarriers for controlled and site-specific drug delivery.
    Balaure PC; Grumezescu AM
    Curr Top Med Chem; 2015; 15(15):1424-90. PubMed ID: 25877097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery.
    Salve R; Kumar P; Ngamcherdtrakul W; Gajbhiye V; Yantasee W
    Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112084. PubMed ID: 33947574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimuli-Responsive Nanomachines and Caps for Drug Delivery.
    Kumar N; Chen W; Cheng CA; Deng T; Wang R; Zink JI
    Enzymes; 2018; 43():31-65. PubMed ID: 30244808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
    Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
    Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
    Liu G; Lovell JF; Zhang L; Zhang Y
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of stimuli-responsive nanoscale drug delivery systems in translational research.
    Gu M; Wang X; Toh TB; Chow EK
    Drug Discov Today; 2018 May; 23(5):1043-1052. PubMed ID: 29155366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
    Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
    Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances on Stimuli-Responsive Combination Therapy against Multidrug-Resistant Bacteria and Biofilm.
    Sikder A; Chaudhuri A; Mondal S; Singh NDP
    ACS Appl Bio Mater; 2021 Jun; 4(6):4667-4683. PubMed ID: 35007019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimuli-responsive polymers for anti-cancer drug delivery.
    Cheng W; Gu L; Ren W; Liu Y
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():600-8. PubMed ID: 25491870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of antibiotics with polymeric particles.
    Xiong MH; Bao Y; Yang XZ; Zhu YH; Wang J
    Adv Drug Deliv Rev; 2014 Nov; 78():63-76. PubMed ID: 24548540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-Responsive Self-Assembled Nanoparticles for Cancer Therapy.
    Li D; Zhang R; Liu G; Kang Y; Wu J
    Adv Healthc Mater; 2020 Oct; 9(20):e2000605. PubMed ID: 32893506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.